Sabrina is committed to meaningfully improving the lives of women. Sabrina founded Daré Bioscience in 2015 (NASDAQ:DARE) because women’s health is an important therapeutic area that deserves dramatically increased attention, investment and innovation. Daré is a biopharmaceutical company driven by our mission to identify, develop and bring to market a diverse portfolio of differentiated therapies that prioritize women’s health and well-being, primarily in the areas of contraception, vaginal health, reproductive health, menopause, sexual health and fertility. By developing and bringing these products to market, we plan to make a difference in the lives of women worldwide.
